New Jersey · 2026-2027 Regular Session · Bill

A 5020: Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.

In committee Last action May 7, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Plain-language summary

A 5020 is a bill introduced in the New Jersey House on May 7, 2026. According to its official title, it concerns: Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services. Primary sponsor: Peterpaul, Luanne M., Esq.. It lists 1 additional sponsor. Most recent recorded action (May 7, 2026): Introduced, Referred to Assembly Financial Institutions and Insurance Committee.

Sponsors

Primary sponsor: Peterpaul, Luanne M., Esq.. 1 co-sponsor.